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Ig class
Percentage of patients diagnosed with 
bronchiectasis Number of patients in each cohort
p-value
Low Ig range Normal Ig range Low Normal Total
IgA 45.0% 31.9% 547 69 616 0.039
IgM 45.4% 34.7% 497 118 615 0.035
IgM & IgA 47.2% 32.4% 564 148 616 0.002
Table 1. The data shows the percentage of patients currently diagnosed with bronchiectasis stratified
by their IgA and/or IgM titre at diagnosis. Low IgA was defined as <0.8g/l and low IgM was defined
as <0.5g/l. For the IgM & IgA analysis patients belonged to the 'normal' cohort if IgA or IgM were
above the the thresholds stated. All patients in the cohort were IgG deficient and receiving
immunoglobulin therapy. The total number of patients in each cohort varies as not all data fields were
complete for all patients.
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Figure 1. The percentage of patients in this cohort that were; IgM, IgA and IgG deficient (complete
antibody deficiency), receiving prophylactic antibiotics and had a diagnosis of bronchiectasis. All
patients in this cohort were IgG deficient and receiving immunoglobulin replacement.
